DSpace Repository
Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial.
- DSpace Home
- →
- Faculty Publications
- →
- Medical
- →
- Journal Article Publications
- →
- Faculty of Community Medicine
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Katherine E Eddy, ….. Muttappa R Gudadinni,...WHO ACTION Trial Collaborators. | |
| dc.date.accessioned | 2023-04-18T10:59:11Z | |
| dc.date.available | 2023-04-18T10:59:11Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Katherine E Eddy,….. Muttappa R Gudadinni,...WHO ACTION Trial Collaborators. Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial. The Lancet Global Health. 10(10):e1523-e1533, 2022. | en_US |
| dc.identifier.issn | 2214109X | |
| dc.identifier.uri | http://hdl.handle.net/123456789/4794 | |
| dc.language.iso | en | en_US |
| dc.title | Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial. | en_US |
| dc.type | Article | en_US |
